FLEETCOR Technologies, Inc. (FLT)

MONTRÉAL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQB:TAKOF) (Frankfurt:A3DP5Y/ABB.F) (“Volatus” or “the Company”), a leader in uncrewed, aerial, and defense technology solutions, is pleased to announce that it has been awarded a defence contract valued at up to CAD $9 million to supply an allied defence organization with a next-generation interim training system for Intelligence, Surveillance, and Reconnaissance (ISR) operations. The award is structured over two years, with an initial tranche of approximately $4.5 million scheduled for delivery in Q1 2026.

- Presentations include pooled post-hoc analysis of the Phase 3 ADMIRAL and COMMODORE data on post-transplant gilteritinib resumption in relapsed or refractory FLT3m+ AML - - Findings from the Phase 3 MORPHO trial in the post-transplant maintenance  setting and Phase 1/2 VICEROY trial in newly diagnosed disease highlight how treatment timing, sequencing and combination approaches may influence outcomes - TOKYO , Dec. 5, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that new data evaluating XOSPATA™ (gilteritinib) across FMS-like tyrosine kinase 3 mutation-positive (FLT3m+) acute myeloid leukemia (AML), including in relapsed or refractory (R/R), newly diagnosed and post-transplant maintenance settings, will be presented at the upcoming American Society of Hematology (ASH) Annual Meeting taking place from 6-9 December 2025 in Orlando, Fla. Through ongoing research with gilteritinib, Astellas is advancing the science of FLT3m+ AML and generating new evidence across the disease stages, to help improve long-term outcomes for people diagnosed with FLT3m+ AML.

Volatus Aerospace Inc. (FLT:CA) Q3 2025 Earnings Call Transcript

Largest quarterly revenue and gross profit figures in Company history Year-to-date Revenue of $26,905,671, up 32% year-over-year Quarterly Revenue of $10,605,438, up 60% year-over-year; blended gross margin of 33% Adjusted EBITDA loss of $660,661, a 52% year-over-year improvement Current cash balance strengthened to approximately $40 million after quarter-end financing Operational milestones included: new defense deployments, advancement of the Condor XL towards commercialization, and progress on Canadian manufacturing and domestic battery supply-chain initiatives MONTREAL and TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQB:TAKOF) (Frankfurt:A3DP5Y/ABB.F) ("Volatus" or "the Company"), a leader in aerial and defense solutions, is pleased to announce its financial results for the three and nine months ended September 30, 2025 (Q3 2025). All dollar figures are stated in Canadian dollars, unless otherwise indicated.

CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically active target doses; initial dose escalation results in 40 patients indicate a manageable safety profile across all doses assessed Company to host in-person event on Monday, December 8, 2025, at 8:00 p.m. ET CAMBRIDGE, Mass.

One-time non-cash accounting adjustment related to the restructuring of the Company's balance sheet No impact on the Company's revenue, gross margin, or cash position during the period Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Volatus Aerospace Inc. (TSXV: FLT) (OTCQX: TAKOF) (FSE: ABB) (the "Company"), a Canadian leader in aerial intelligence and cargo solutions, today announced that it has restated its financial statements and management's discussion and analysis ("MD&A") for the three and six months ended June 30, 2025. The restatement reflects a non-cash, one-time accounting adjustment of $2,231,202 related to the restructuring of the Company's balance sheet, as previously announced on May 22, 2025 and April 11, 2025, and the modification and retirement of certain debt instruments.

MONTREAL, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT) ( OTCQB: TAKOF) (FSE: ABB.F), a Canadian leader in aerial intelligence and unmanned aircraft systems, is excited to announce its participation in the upcoming 2025 Maxim Growth Summit, taking place from October 22nd to 23rd at The Hard Rock Hotel NYC. This prestigious event brings together industry leaders, innovators, and premier institutions to explore the latest trends and advancements across several industries.

MONTREAL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT) (OTCQB: TAKOF) (FSE: ABB.F), a Canadian leader in aerial intelligence and unmanned aircraft systems, and VoltaXplore Inc., a high-performance lithium-ion battery manufacturer and subsidiary of NanoXplore Inc. (TSX: GRA) (OTCQX: NNXPF), are pleased to announce the signing of a Letter of Intent (the “LOI”) for the future supply of Canadian-made lithium-ion battery cells to power Volatus' next-generation drones.

MONTREAL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT) (OTCQB: TAKOF) (FSE: ABB.F), a Canadian leader in aerial intelligence and unmanned aircraft systems, and VoltaXplore Inc., a high-performance lithium-ion battery manufacturer and subsidiary of NanoXplore Inc. (TSX: GRA) (OTCQX: NNXPF), are pleased to announce the signing of a Letter of Intent (the “LOI”) for the future supply of Canadian-made lithium-ion battery cells to power Volatus' next-generation drones.

TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT) (OTCQB: TAKOF) (FSE: ABB.F) (“Volatus” or the “Company”), is pleased to announce that it has entered into a multi-year agreement with one of North America's largest electricity transmission and distribution utilities.

Revenue of $10,587,075 in Q2 2025, up 49% year-over-year; gross margin of 32% Adjusted EBITDA loss of $276,259, an 85% year-over-year improvement Current cash balance strengthened to approximately $20M Operational highlights included clearances and demonstrations with defense and energy clients and new commercial wins in forestry and agriculture. Subsequent events included additional NATO-aligned contracts and growth capital TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQB:TAKOF) (Frankfurt:A3DP5Y/ABB.F) ("Volatus" or "the Company"), a leader in aerial solutions, is pleased to announce its financial results for the three and six months ended June 30, 2025 (Q2 2025).

Addition of Tuspetinib (TUS) to Venetoclax (VEN) and Azacitidine (AZA) is being developed as safe and mutation agnostic frontline therapy for AML Addition of TUS to VEN+AZA improves response rates; 100% CR/CRh at 80 mg and 120 mg Addition of TUS to VEN+AZA improves MRD-negativity rates; 78% among responders 100% CR/CRh in FLT3 wildtype AML, representing 70% of AML population 100% CR/CRh and MRD-negativity rates in TP53, RAS and FLT3-ITD mutated AML Broad spectrum activity and excellent safety profile continue at 120 mg dose to date SAN DIEGO and TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (OTC: APTOF, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly diagnosed AML, today provided a data update from the Phase 1/2 TUSCANY trial in newly diagnosed AML. The trial was initiated in December 2024, and the growing body of positive data includes the recently completed third cohort of 120 mg TUS in the TUS+VEN+AZA triplet therapy.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”) is pleased to announce that it has completed its previously announced bought deal private placement offering of securities, including the exercise in full of the Underwriter's (as defined below) over-allotment option, of a total of 9,288,462 units of the Company (the “Offered Securities”) at a price of $0.52 per Offered Security for gross proceeds of $4,830,000 (the “Offering”). The Offering was led by institutional investors in Quebec, with strong participation from additional institutional investors across Canada, underscoring the broad confidence in Volatus' strategy and growth potential.The Offering was led by Ventum Financial Corp. as underwriter and sole bookrunner (the “Underwriter”).

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”) is pleased to announce it has entered into an agreement with Ventum Financial Corp. (the "Underwriter") in connection with a bought deal private placement of 8,076,924 units of the Company (the “Offered Securities”) at a price of $0.52 per Offered Security (the “Issue Price”) for gross proceeds of $4,200,000 (the “Offering”).   Each Offered Security will consist of one common share of the Company and one-half of one common share purchase warrant of the Company (each whole warrant, a “Warrant”), with each whole Warrant entitling the holder thereof to acquire one common share of the Company at an exercise price of $0.76 and for a period of 36 months following the Closing Date (as defined below).

TORONTO, July 23, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB), a Canadian leader in aerial intelligence and cargo solutions, is pleased to announce the launch of its Condor XL heavy-lift drone program. Drawing on decades of helicopter operations experience, in-house avionics capabilities, and a renewed focus on rotorcraft-specific training, the company is introducing a next-generation platform designed to meet global demand for autonomous, heavy-lift drone solutions.

TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Corp. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) ("Volatus" or the "Company") is pleased to announce that it has been awarded a contract valued at approximately $560,000 CAD to provide advanced training in drone operations and sensor payload utilization to support aerial intelligence. The contract reinforces the Company's role as a trusted provider of mission-critical capabilities for government programs.